Quarterly report pursuant to Section 13 or 15(d)

FINANCIAL INSTRUMENTS (Tables)

v3.24.2.u1
FINANCIAL INSTRUMENTS (Tables)
6 Months Ended
Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The following table presents the classification of the Company’s financial instruments that are required to be measured at fair value on a recurring basis on the Company’s Condensed Consolidated Balance Sheets (in thousands):
June 30, 2024 December 31, 2023
Current assets:
Natural gas financial instruments $ —  $ — 
Current liabilities:
Embedded derivatives 4,665  13,332 
Long-term liabilities:
Embedded derivatives 7,648  18,892 
Schedule of Derivative Instruments, Gain (Loss)
The following table summarizes the effect of the Company’s financial instruments on the Condensed Consolidated Statements of Operations (in thousands):
Three Months Ended June 30, Six Months Ended June 30,
2024 2023 2024 2023
Natural gas financial instruments:
Realized gain $ —  $ 11,444  $ —  $ 23,310 
Unrealized loss —  (10,891) —  (10,463)
Embedded Derivatives
Realized loss (6,426) —  (8,571) — 
Unrealized gain 6,198  —  4,239  — 
Schedule of Derivative Instruments
The following table summarizes changes in the Company’s Embedded Derivatives (in thousands):
Six Months Ended June 30, 2024
Balance at January 1, 2024 $ 32,225 
Issued — 
Settled (24,243)
Total gains or losses (realized and unrealized) included in earnings 4,332 
Balance at June 30, 2024
$ 12,314